What is the Genentech patient Foundation?
Genentech Patient Foundation Living with a serious illness can come with many challenges. Getting Genentech medicines shouldn’t be one of them. The Genentech Patient Foundation gives free Genentech medicine to people who don’t have insurance coverage or who have financial concerns.
How can I get Free Genentech medicine?
‡ To be eligible for free Genentech medicine from the Genentech Patient Foundation, insured patients who have coverage for their medicine should try to pursue other forms of financial assistance, if available, and meet certain income requirements.
What is Genentech-access solutions?
Access Solutions is a program from Genentech and is committed to helping you understand your insurance coverage and options that might be able to help you pay for your Genentech medicine. Call (866) 422-2377or visit Genentech-Access.comfor more information. What to expect after applying?
How do I enroll in Genentech access solutions?
If you are concerned about paying for your Genentech medicine, please call our Patient Resource Center at (877) 436-3683. Ready to Enroll? Fill out the Patient Consent Form and send it to Genentech Access Solutions to get started. The form can be submitted in any of these 3 ways:
See more
What is the Genentech Patient Foundation?
The Genentech Patient Foundation gives free medicine to people who have financial concerns, because we believe that every person who is prescribed a Genentech medicine should get the treatment they need. Help for People With or Without Health Insurance.
What is Genentech access solutions?
Genentech Access Solutions Explains insurance coverage to people taking Genentech medicines and connects them to support programs.
What drugs does Genentech make?
Our Medicines & ProductsMedicines.Actemra® (TOCILIZUMAB [authorized for Emergency Use])Actemra® (tocilizumab)Activase® (alteplase)Alecensa® (alectinib)Avastin® (bevacizumab)Boniva Tablets® (ibandronate sodium)Cathflo Activase® (alteplase)More items...
Who makes Valganciclovir?
Genentech: Valcyte® (valganciclovir hydrochloride) - Information for Patients.
What is Ophthalmology access solutions?
We focus on access so you can focus on health Genentech Ophthalmology Access Solutions is a program that helps people who are taking a Genentech medicine. Your health insurance plan and the cost of your medicine might keep you from getting your prescribed treatment.
Does Pfizer own Genentech?
Roche Holding's agreement on Thursday to acquire full ownership of Genentech for $46.8 billion is the third big drug industry merger this year. But it is different from the other two — Pfizer's $68 billion proposal to acquire Wyeth and Merck's $41 billion deal with Schering-Plough — in crucial ways.
What is Genentech best known for?
Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
Why did Roche buy Genentech?
For another, Roche went into the deal with the goal of preserving the innovative, entrepreneurial culture that had transformed Genentech from a start-up to a standout, one that had developed Roche's three best-selling products — the cancer drugs Avastin, Herceptin and Rituxan.
How many drugs does Genentech have?
Genentech, Inc. manufactures, markets and/or distributes more than 47 drugs in the United States.
Which one of these is an approved drug by the firm Genentech?
The Genentech medicines supported by the Genentech Patient Foundation are: Actemra® (tocilizumab) Activase® (alteplase) Alecensa® (alectinib)
What drugs does Roche make?
All. Actemra/RoActemra. Alecensa. ... Anaemia. Mircera. NeoRecormon.Cancer (blood tumours) Gazyva/Gazyvaro. MabThera / Rituxan. ... Cancer (blood cancers) Alecensa. Avastin. ... Dermatology. Roaccutane/Accutane.Haemophilia. Hemlibra.Infectious Diseases. Actemra/RoActemra. Copegus. ... Inflammatory & Autoimmune Diseases. Actemra/RoActemra. CellCept.More items...
What MS drugs does Genentech make?
About OCREVUS OCREVUS is approved by the FDA to treat relapsing or primary progressive forms of multiple sclerosis (MS).
How to contact Genentech patient foundation?
For a current list of the medications supported by the Genentech Patient Foundation, please visit GenentechPatientFoundation.com or call (888) 941-3331.
What to attach to patient's insurance card?
If patient is insured, attach insurance card(s) or demographics sheet with insurance information
What is access solutions?
Access Solutions is a program from Genentech and is committed to helping you understand your insurance coverage and options that might be able to help you pay for your Genentech medicine. Call (866) 422-2377or visit Genentech-Access.comfor more information.
